Sex, lies, + pharmaceuticals : how drug companies plan to profit from female sexual dysfunction
(Book)
Author
Contributors
Status
General Shelving - 3rd Floor
HD9665.5 .M692 2010
1 available
HD9665.5 .M692 2010
1 available
Description
Loading Description...
Also in this Series
Checking series information...
Copies
| Location | Call Number | Status |
|---|---|---|
| General Shelving - 3rd Floor | HD9665.5 .M692 2010 | On Shelf |
Subjects
LC Subjects
OCLC Fast Subjects
Other Subjects
Conflict of Interest -- economics
Drogues et sexualité.
Drug Industry
Drug Industry -- economics
Farmaceutische industrie.
Femmes -- Sexualité.
Frau.
Geneesmiddelen.
Genital Diseases, Female -- economics
Industrie pharmaceutique -- Aspect moral.
Industrie pharmaceutique -- Aspect économique.
Industrie pharmaceutique.
Marketing of Health Services -- economics
Médicaments -- Commercialisation.
Médicaments -- Publicité.
Pharmaceutical industry -- Economic aspects.
Pharmaceutical industry -- Ethical aspects.
Pharmakotherapie.
Pharmazeutische Industrie.
Seksuele stoornissen.
Sexual disorders -- Economic aspects.
Sexual disorders.
Sexual Dysfunction, Physiological -- drug therapy
Sexual Dysfunctions, Psychological -- drug therapy
Sexualstörung.
Troubles du désir sexuel -- Aspect économique.
Troubles sexuels -- Aspect économique.
Wirtschaftlichkeit.
Women -- Sexual behavior.
Drogues et sexualité.
Drug Industry
Drug Industry -- economics
Farmaceutische industrie.
Femmes -- Sexualité.
Frau.
Geneesmiddelen.
Genital Diseases, Female -- economics
Industrie pharmaceutique -- Aspect moral.
Industrie pharmaceutique -- Aspect économique.
Industrie pharmaceutique.
Marketing of Health Services -- economics
Médicaments -- Commercialisation.
Médicaments -- Publicité.
Pharmaceutical industry -- Economic aspects.
Pharmaceutical industry -- Ethical aspects.
Pharmakotherapie.
Pharmazeutische Industrie.
Seksuele stoornissen.
Sexual disorders -- Economic aspects.
Sexual disorders.
Sexual Dysfunction, Physiological -- drug therapy
Sexual Dysfunctions, Psychological -- drug therapy
Sexualstörung.
Troubles du désir sexuel -- Aspect économique.
Troubles sexuels -- Aspect économique.
Wirtschaftlichkeit.
Women -- Sexual behavior.
More Details
Format
Book
Physical Desc
xi, 257 pages ; 22 cm
Language
English
Notes
Bibliography
Includes bibliographical references (pages 223-242) and index.
Description
Reveals how womens' sexual difficulties are being repackaged as symptoms of a new disorder and investigates the creation of female sexual dysfunction or FSD, and the marketing machine that promises to "cure" it.
Additional Physical Form
Issued also in electronic format.
Local note
SACFinal081324
Reviews from GoodReads
Loading GoodReads Reviews.
Citations
APA Citation, 7th Edition (style guide)
Moynihan, R., & Mintzes, B. (2010). Sex, lies, + pharmaceuticals: how drug companies plan to profit from female sexual dysfunction . Greystone Books.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)Moynihan, Ray and Barbara. Mintzes. 2010. Sex, Lies, + Pharmaceuticals: How Drug Companies Plan to Profit From Female Sexual Dysfunction. Greystone Books.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)Moynihan, Ray and Barbara. Mintzes. Sex, Lies, + Pharmaceuticals: How Drug Companies Plan to Profit From Female Sexual Dysfunction Greystone Books, 2010.
MLA Citation, 9th Edition (style guide)Moynihan, Ray., and Barbara Mintzes. Sex, Lies, + Pharmaceuticals: How Drug Companies Plan to Profit From Female Sexual Dysfunction Greystone Books, 2010.
Note! Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of August 2021.
Staff View
Loading Staff View.